About 30% of people with depression experience TRD.
Depression is a common but serious mental health condition.
It’s characterized by a sad mood and lack of interest in activities for at least two weeks.
RJ Sangosti/MediaNews Group/The Denver Post via Getty Images / Contributor / Getty Images
Depression interferes with daily life and can be debilitating.
Symptoms of depression vary but may include fatigue, feelings of hopelessness, irritability, and trouble concentrating.
Finding the proper treatment for it is crucial to improve daily life and prevent complications like suicide.
If you or a loved one are in immediate danger, call911.
Here’s a closer look:
Summary
Ketamine is a medicine approved for surgical anesthesia.
It is taken off-label for depression.
In contrast to other antidepressants, ketamine begins to work within hours.
For this reason, it is a good option for people with severe depression or those with suicidal thoughts.
Ketamine is usually given as an IV infusion in a healthcare setting like a hospital or specialized clinic.
Yavi M, Lee H, Henter ID, et al.Ketamine treatment for depression: a review.Discov Ment Health.
Jelen LA, Stone JM.Ketamine for depression.Int Rev Psychiatry.
2021;51(3):109-124.
2016;32(6):557-564. doi:10.1007/s12264-016-0081-2
Adell A.Brain NMDA receptors in schizophrenia and depression.Biomolecules.
2020;10(6):947.
Published 2023 Jan 28. doi:10.2147/JPR.S403323
Sobule R, Ithman M.Ketamine: studies show benefit.Mo Med.
2023;120(1):29-30.
Rosenblat JD, Carvalho AF, Li M, et al.Oral ketamine for depression: a systematic review.
2020 Apr 22;81(2):20lcx13315.
doi: 10.4088/JCP.20lcx13315].J Clin Psychiatry.
2019;80(3):18r12475.
Published 2019 Apr 16. doi:10.4088/JCP.18r12475
U.S. Food and Drug Administration.SPRAVATOTM (esketamine) nasal spray, CIII prescribing information.
2022;63(5):726-733. doi:10.1016/j.amepre.2022.05.014
National Institute of Mental Health.Major depression.
National Institute of Mental Health.Depression.
2021;9(31):9350-9367. doi:10.12998/wjcc.v9.i31.9350
Department of Justice/ Drug Enforcement Administration Drug Fact Sheet.Ketamine.
2021;82(4):20r13459.
Published 2021 Feb 26. doi:10.3389/fphar.2021.640241
ASKP3.Directory.
Voineskos D, Daskalakis ZJ, Blumberger DM.Management of treatment-resistant depression: challenges and strategies.Neuropsychiatr Dis Treat.
Published 2020 Jan 21. doi:10.2147/NDT.S198774
